H Kaji, Y Imanishi, T Sugimoto… - Experimental and clinical …, 2011 - ncbi.nlm.nih.gov Wnt-β-catenin signaling is important for bone formation. Sclerostin inhibits bone formation mainly by suppressing this signal, and several studies suggest that the suppression of sclerostin expression contributes to the bone anabolic action of parathyroid hormone (PTH). We therefore ...
WH Chong, AA Molinolo, CC Chen… - Endocrine-Related …, 2011 - Soc Endocrinology Tumor-induced osteomalacia (TIO) is a rare and fascinating paraneoplastic syndrome in which patients present with bone pain, fractures, and muscle weakness. The cause is high blood levels of the recently identified phosphate and vitamin D-regulating hormone, fibroblast growth ... Related articles - All 3 versions
N Saidenberg-Kermanac'h, L Souabni, V Prendki… - Joint Bone Spine, 2011 - Elsevier The antiretroviral agent tenofovir can cause hypophosphatemic osteomalacia due to renal phosphate wasting. The potential role for Fibroblast Growth Factor 23 (FGF23), a phosphaturic hormone is unknown. We evaluated FGF23 plasma concentrations in an HIV-positive patient with ... Cited by 1 - Related articles - All 2 versions
H Kawate, A Taketomi, T Watanabe… - …, 2011 - journals.lww.com Wolters Kluwer Health may email you for journal alerts and information, but is committed to maintaining your privacy and will not share your personal information without your express consent. For more information, please refer to our Privacy Policy. ... Skip Navigation Links Home > Current ... Related articles - All 3 versions
D Walker, S Robinson, Y Jagatsinh… - Journal of Visual …, 2011 - informahealthcare.com Objective: To explore the appropriateness of the images in the Arthritis Research UK Mind-Map for Osteomalacia with people for whom it was intended (Bengali; Gujarati; Hindi; Punjabi and Urdu). Methods: Participants were identified in a convenient sample from contacts within ...
沪公网安备号：31010402006960 （网站）31010405000484 （蝌蝌APP）
安全保密
